News
Biocytogen Announces RenLite Licensing Agreement with Janssen
Biocytogen Pharmaceuticals announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the agreement, Biocytogen grants Janssen and its affiliates a non-exclusive worldwide license to use...
Drug Research
Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
Crown Bioscience , a global contract research organization and JSR Life Sciences company, announced the opening of a new location in Singapore to expand the company's capacity to serve both global and support local biotech and pharmaceutical companies engaged...
News
Lonza Upgrades Powder Characterization Capabilities
Lonza recently announced a significant enhancement to its powder characterization capabilities at its Small Molecules site in Tampa, Florida, US. The facility has been upgraded to include universal powder flow testing alongside automated particle size and shape analysis capabilities....
Drug Research
Sandoz signs MoU to build new biologics production plant in Slovenia, to support increasing global demand for biosimilar medicines
Sandoz, a global leader in generic and biosimilar medicines, signed a Memorandum of Understanding (MoU) to build a new biologics production plant in Lendava, Slovenia.
The Sandoz investment is expected to be at least USD 400 million, supporting the company’s...
Clinical Trials
Shuttle Pharmaceuticals Engages UI Pharmaceuticals for Formulation and Clinical Batch Manufacture of Ropidoxuridine for Brain Tumor Clinical Trial
Shuttle Pharmaceuticals Holdings, Inc., a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals...
Drug Research
Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology
Simris Alg AB, a European biologics company focused on extracting high value biological active compounds from microalgae and cyanobacteria, announced a framework collaboration agreement with Lonza Ltd, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, to commercialize...
Clinical Trials
Clinical Trial Registration Enhanced By Default Eligibility
A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown positive results.
The patient outreach recruitment team that has been floated by the South Carolina Clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.